Because Vision Protection Therapy™ improves retinal function and health in virtually any setting, it can be used to help many problems that patients and their retina doctors encounter every day. Some of these have no other treatment.
For others, like Central Serous Retinopathy (CSR), the alternative treatments are more difficult, expensive and have side-effects. VPT™ is highly effective for CSR and a number of retinal disorders that can benefit from the improvements in retinal function safely caused by VPT™.
For all, the unique safety and effectiveness of VPT™ make it a logical first choice.
Central serous chorioretinopathy before (top) and after (bottom) VPT™.
Fluorescein (left) and indocyanine green (right) angiogram of chronic central serous chorioretinopathy
Spectral domain OCT of chronic central serous chorioretinopathy before (above) and after (below) VPT™. Note resolution of macular edema.
Macular edema due to sarcoid uveitis before (above) and after (below) VPT™.
Persistent macular edema with blurred vision after retinal surgery (top). Visual acuity and macular edema improved 3 months after VPT™.
Persistent macular edema with blurred vision after retinal surgery (top). Visual acuity and macular edema improved 3 months after VPT™.
Macular telangiectasia before (above) and after (below) VPT™.
Improved macular architecture after VPT™ alone. Before (above) and after (below) VPT™.
Eye with epiretinal membrane improved by VPT™ alone (no surgery).